{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:34:16Z","timestamp":1737610456215,"version":"3.33.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,22]]},"DOI":"10.7759\/cureus.77846","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:09:04Z","timestamp":1737590944000},"source":"Crossref","is-referenced-by-count":0,"title":["Solitary Ocular Plasmacytoma: Exploring a Rare Extramedullary Tumor"],"prefix":"10.7759","author":[{"given":"Andrea","family":"Gonz\u00e1lez-Espinoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Flores-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abelardo A","family":"Rodriguez-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Zambrano-Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00499-8","article-title":"Solitary plasmacytoma: a review of diagnosis and management","volume":"14","author":"Pham A","year":"2019","unstructured":"Pham A, Mahindra A. Solitary plasmacytoma: a review of diagnosis and management. Curr Hematol Malig Rep. 2019, 14:63-9. 10.1007\/s11899-019-00499-8","journal-title":"Curr Hematol Malig Rep"},{"key":"ref2","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"1186","author":"Caers J","year":"2018","unstructured":"Caers J. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol. 2018, 1186:13045.","journal-title":"J Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni E","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, et al.. Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. 2011, 118:5989-95. 10.1182\/blood-2011-06-361386","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame R","year":"2012","unstructured":"Warsame R, Gertz MA, Lacy MQ, et al.. Trends and outcomes of modern staging of solitary plasmacytoma of bone. Am J Hematol. 2012, 87:647-51. 10.1002\/ajh.23201","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10350","article-title":"Radiotherapy for solitary bony or extramedullary plasmacytoma","volume":"4","author":"Katano A","year":"2024","unstructured":"Katano A, Sawayanagi S, Minamitani M, Ohira S, Yamashita H. Radiotherapy for solitary bony or extramedullary plasmacytoma. Cancer Diagn Progn. 2024, 4:470-4. 10.21873\/cdp.10350","journal-title":"Cancer Diagn Progn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2019.00570","article-title":"The predictive value of serum myeloma protein in solitary plasmacytoma","volume":"38","author":"Chang WI","year":"2020","unstructured":"Chang WI, Koh HK, Yoon SS, Kim HS, Eom KY, Kim IH. The predictive value of serum myeloma protein in solitary plasmacytoma. Radiat Oncol J. 2020, 38:129-37. 10.3857\/roj.2019.00570","journal-title":"Radiat Oncol J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11769","article-title":"Clinical features of head and neck solitary extramedullary plasmacytoma in Taiwan","volume":"34","author":"Lai CY","year":"2020","unstructured":"Lai CY, Hsieh HH, Chen HK, et al.. Clinical features of head and neck solitary extramedullary plasmacytoma in Taiwan. In Vivo. 2020, 34:261-5. 10.21873\/invivo.11769","journal-title":"In Vivo"},{"key":"ref8","article-title":"Multiple myeloma current treatment algorithms","volume":"28","author":"Rajkumar SV","year":"2020","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020, 28:94.","journal-title":"Blood Cancer J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020265","article-title":"Proteasome inhibitors for the treatment of multiple myeloma","volume":"12","author":"Ito S","year":"2020","unstructured":"Ito S. Proteasome inhibitors for the treatment of multiple myeloma. Cancers (Basel). 2020, 12:265. 10.3390\/cancers12020265","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers J","year":"2018","unstructured":"Caers J, Paiva B, Zamagni E, et al.. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol. 2018, 11:10. 10.1186\/s13045-017-0549-1","journal-title":"J Hematol Oncol"},{"key":"ref11","article-title":"The role of PET-CT in the management of patients with multiple myeloma","volume":"100","author":"Kastritis E","year":"2015","unstructured":"Kastritis E, Terpos E, Moulopoulos LA, et al.. The role of PET-CT in the management of patients with multiple myeloma. Haematologica. 2015, 100:889-900.","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2","article-title":"Multiple myeloma: current treatment algorithms","volume":"35","author":"Rajkumar SV","year":"2020","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: current treatment algorithms. Oncology. 2020, 35:158-63. 10.1038\/s41408-020-00359-2","journal-title":"Oncology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0225","article-title":"The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future","volume":"16","author":"Pozzi S","year":"2011","unstructured":"Pozzi S, Raje N. The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. Oncologist. 2011, 16:651-62. 10.1634\/theoncologist.2010-0225","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1881","article-title":"New strategies in the treatment of multiple myeloma","volume":"19","author":"Munshi NC","year":"2013","unstructured":"Munshi NC, Anderson KC. New strategies in the treatment of multiple myeloma. Clin Cancer Res. 2013, 19:3337-44. 10.1158\/1078-0432.CCR-12-1881","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S53248","article-title":"Prognostic factors associated with solitary plasmacytoma","volume":"6","author":"Guo SQ","year":"2013","unstructured":"Guo SQ, Zhang L, Wang YF, et al.. Prognostic factors associated with solitary plasmacytoma. Onco Targets Ther. 2013, 6:1659-66. 10.2147\/OTT.S53248","journal-title":"Onco Targets Ther"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V86.4.1453.bloodjournal8641453","article-title":"CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples","volume":"86","author":"Mason DY","year":"1995","unstructured":"Mason DY, Cordell JL, Brown MH, et al.. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995, 86:1453-9.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00137","article-title":"Immunophenotype of normal and myelomatous plasma-cell subsets","volume":"5","author":"Robillard N","year":"2014","unstructured":"Robillard N, Wuill\u00e8me S, Moreau P, B\u00e9n\u00e9 MC. Immunophenotype of normal and myelomatous plasma-cell subsets. Front Immunol. 2014, 5:137. 10.3389\/fimmu.2014.00137","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316362-solitary-ocular-plasmacytoma-exploring-a-rare-extramedullary-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:09:05Z","timestamp":1737590945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316362-solitary-ocular-plasmacytoma-exploring-a-rare-extramedullary-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.77846","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}